Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page
- Check2 days agoChange DetectedAdded Qiryat Krinitzi, Israel, 52621 as a study site and removed Tel Litwinsky, Israel, 52621. Updated page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedDirect contact details for the AstraZeneca Cancer Study Locator (phone and email) were added to the page. The addition also includes AstraZeneca attribution and a 'Helpful Links Provided by' label.SummaryDifference0.1%

- Check23 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a minor release of the page rather than a change to study information.SummaryDifference0.0%

- Check30 days agoChange DetectedZaporizhzhia, Ukraine, 69040 in the study's locations list has been updated to Zaporizhzhya, Ukraine, 69040.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This appears to be a minor build or content update without visible changes to the page content.SummaryDifference0.0%

- Check59 days agoChange DetectedA new page revision tag was added: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer
Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.